Principles for Artificial Intelligence in Medical Technology
This document provides the medical device industry’s foundational principles for artificial intelligence in medical technology. These principles will guide further innovations, policymaking, and regulations in AI-enabled medical technology.
Related Reading
Event / Digital Health / Regulatory Affairs
Shifting Customer Engagement Models in Diagnostics: Winning in a Rapidly Evolving Market
September 29, 2026
2:00 PM – 3:00 PM
Join Deloitte in this discussion examining how rising consumer expectations, new technology entrants, and evolving provider roles are reshaping how diagnostics manufacturers engage their customers.
Event / Digital Health / Regulatory Affairs
Reimagining the Cost of Quality: The Agentic AI Opportunity for MedTech
September 30, 2026 10:00AM – 11:00AM ET
Join HCLTech in this discussion about practical use cases and strategies to scale AI-driven quality operations while maintaining compliance and enabling greater innovation.
News / Coverage & Payment / Health Access / Regulatory Affairs
AdvaMed Welcomes Expiration of Moratorium on New Medicare Durable Medical Equipment Suppliers
August 27, 2026
WASHINGTON—Scott Whitaker, president and CEO of AdvaMed, the medtech association, today welcomed the expiration of the moratorium on Medicare acceptance of Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) suppliers. He made the following comment on the expiration.
Blog / Artificial Intelligence (AI) / Digital Health / Health Access
The Insight Series: AI & Digital Health with Kelly Huang
August 27, 2026
“The Insight Series: AI & Digital Health” features industry experts answering key questions to help inform policymakers and the public about how AI is shaping the future of care delivery. This edition features Kelly Huang, CEO of Elucid, an AI medical technology company focused on providing physicians with a more precise, non-invasive view of atherosclerosis to drive patient-specific cardiovascular care.
News / Diagnostics / Medical Imaging / Regulatory Affairs
Cubresa Announces FDA 510(k) Clearance for the Cubresa BrainPET™ Scanner, Opening New Frontier in Clinical Brain Imaging
August 20, 2026
WINNIPEG, MANITOBA, CANADA, August 20, 2026 /EINPresswire.com/ — Cubresa Inc., a global leader in clinical and preclinical molecular imaging technologies, today announced that it has received FDA 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its groundbreaking Cubresa BrainPET™ scanner.
News / Diagnostics / Digital Health / Government & Legislative Affairs / Regulatory Affairs
AdvaMed Statement on the Nomination of Dr. Heidi Overton as FDA Commissioner
August 19, 2026
WASHINGTON—Scott Whitaker, president and CEO of AdvaMed, the medtech association, made the following comment on President Trump’s nomination of Dr. Heidi Overton to serve as FDA commissioner.
Event / Digital Health / Regulatory Affairs
Software as a Medical Device: From Regulatory Strategy to Market Readiness
September 16, 2026
12:00 PM – 1:00 PM
Join MIDI as they provide a practical framework for developing SaMD products with regulatory requirements built into the development process.
Event / Regulatory Affairs
From Data Chaos to Trusted AI in MedTech:
Data Quality, Knowledge Graphs & Semantic Layers That Make It Possible
September 10, 2026
12:00 PM – 1:00 PM
Join Genpact as they provide a practical framework for connecting, governing, and activating service data – and a clear roadmap for scaling AI from pilot to confident business outcomes.